| DIRECT COMPETITOR COMPARISON | |
| NATR | HLF | NUS | Pvt1 | Industry | | Market Cap: | 145.79M | 2.49B | 1.73B | N/A | 112.54M | | Employees: | 1,183 | 4,000 | 9,185 | N/A | 280 | | Qtrly Rev Growth (yoy): | -7.40% | -0.30% | 7.70% | N/A | 9.60% | | Revenue (ttm): | 341.31M | 2.21B | 1.27B | N/A | 71.35M | | Gross Margin (ttm): | 79.68% | 46.62% | 81.53% | N/A | 49.96% | | EBITDA (ttm): | 9.75M | 338.70M | 175.03M | N/A | 724.20K | | Oper Margins (ttm): | 1.54% | 12.65% | 11.50% | N/A | 7.94% | | Net Income (ttm): | 1.62M | 181.35M | 74.02M | N/A | N/A | | EPS (ttm): | 0.105 | 2.862 | 1.160 | N/A | N/A | | P/E (ttm): | 89.52 | 14.27 | 23.74 | N/A | 17.97 | | PEG (5 yr expected): | N/A | 0.92 | 1.3 | N/A | 0.94 | | P/S (ttm): | 0.43 | 1.11 | 1.35 | N/A | 1.29 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.42 | 0.12% | 58.12B | 12.52 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 52.24 | 0.15% | 15.11B | 17.48 | | Genzyme Corp. | GENZ | 48.50 | 0.62% | 12.87B | 27.65 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 43.00 | -0.02% | 38.70B | 16.63 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 52.17 | 0.68% | 9.30B | 1064.69 | | Teva Pharmaceutical Industries Limited | TEVA | 55.94 | -0.07% | 49.28B | 51.18 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 39.91 | 0.28% | 4.24B | 20.57 | | King Pharmaceuticals Inc. | KG | 12.14 | -0.82% | 3.01B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.74 | 0.00% | 5.73B | 114.97 | | Pfizer Inc. | PFE | 18.60 | 0.11% | 150.09B | 15.45 | | Johnson & Johnson | JNJ | 64.70 | 0.20% | 178.51B | 14.13 | | GlaxoSmithKline plc | GSK | 42.29 | 0.48% | 107.21B | 13.87 | | Sanofi-Aventis | SNY | 39.87 | 0.43% | 104.11B | N/A | | Novartis AG | NVS | 54.84 | 0.44% | 124.55B | 16.42 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 43.20 | 0.93% | N/A | N/A | | AstraZeneca plc | AZN | 46.38 | 0.89% | 67.25B | 9.31 | | Abbott Laboratories | ABT | 54.15 | 0.11% | 83.76B | 14.67 | | Bristol-Myers Squibb Co. | BMY | 25.76 | 0.23% | 51.03B | 13.33 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | HLF | | Herbalife Enters Oversold Territory
Tue, Dec 22 -
Zacks.com | | • | HLF | | HERBALIFE LTD. Files SEC form 8-K, Change in Directors or Principal Officers
Mon, Dec 21 -
EDGAR Online | | • | NUS | | NewMarket Corp. (NEU): Zacks Rank Buy
Mon, Dec 21 -
Zacks.com | | • | NUS | | Zacks Releases Four Powerful ''Buy'' Stocks: Ecopetrol S.A., Nu Skin Enterprises, Bio Rad Laboratories, Inc. and Magellan Health Services Inc.
Fri, Dec 18 -
Zacks.com | | • | NUS | | Nu Skin Japan Celebrates ageLOC Product Launch
Fri, Dec 18 -
PR Newswire | | • | NUS | | Nu Skin Enterprises (NUS): Zacks Rank Buy
Fri, Dec 18 -
Zacks.com | | • | HLF | | Herbalife reaffirms 2009, 2010 profit outlooks
Wed, Dec 16 -
AP | | • | HLF | | UPDATE - Herbalife reaffirms FY09 earnings outlook
Wed, Dec 16 -
at Reuters | | • | HLF | | Herbalife Announces Executive Management Promotions
Wed, Dec 16 -
Business Wire | | • | HLF | | Streetwalker: Five Cash-Rich Companies
Tue, Dec 8 -
at Forbes.com | | • | NUS | | 10 Small-Caps That Can Go the Distance
Mon, Dec 7 -
at TheStreet.com | | • | NUS | | Herbalife Ltd. (HLF): Zacks Rank Buy
Mon, Dec 7 -
Zacks.com | | • | NUS | | Playing Into Vanity: Under the Radar
Fri, Dec 4 -
at TheStreet.com | | • | NUS | | Zacks Releases Four Powerful ''Buy'' Stocks: Harbin Electric, Inc., NewMarket Corporation, Nu Skin Enterprises and Wright Express Corporation
Tue, Dec 1 -
Zacks.com | | • | NUS | | Nu Skin Enterprises (NUS): Zacks Rank Buy
Tue, Dec 1 -
Zacks.com | | • | NUS | | A Relative Price Strength Screen for All Markets
Wed, Nov 25 -
Zacks.com | | • | NUS | | Why Consumers Still Spend on Beauty
Tue, Nov 17 -
at Minyanville.com | | • | NUS | | Why Consumers Still Spend on Beauty
Tue, Nov 17 -
at Minyanville.com | | | All Headlines for these symbols... |
|
|
|
0.51% Nasdaq 
Competitors
